Publication | Closed Access

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia

Antimicrobial Resistance GeneHealth SciencesMedicineProphylactic Fluoroquinolone UseEscherichia ColiAntimicrobial TherapyCancer CenterInfection ControlAntimicrobial ChemotherapyAntibiotic ResistanceOncologyRadiation OncologyClinical MicrobiologyAntimicrobial ResistanceCancer ResearchDrug Resistance